Back to results
US 2003/0166731 A1Published application
Method of treating hair loss using diphenylether derivatives
AssigneeThe University of Texas Southwestern Medical Center
InventorsLixin Lilly Zhang, Robert Scott Youngquist
Life of this patent
Estimating the term…
Abstract
The present disclosure describes methods for treating hair loss in mammals, including arresting and/or reversing hair loss and promoting hair growth. The methods comprise administering a cardiac-sparing compound having a structure of formula (I) as described herein and a pharmaceutically-acceptable carrier. 1
Claims10
A method of treating hair loss comprising administering a composition comprising a cardiac-sparing compound characterized by the structure:
- 15
- and pharmaceutically acceptable salts, hydrates, and biohydrolyzable amides, esters, and imides thereof, wherein:
- R is selected from the group consisting of hydrogen, hydroxy, esterified hydroxy, and etherified hydroxy;
- R1, R2, and R4 are each, independently, selected from the group consisting of hydrogen, halogen, trifluoromethyl and lower alkyl;
- R3 is selected from the group consisting of halogen, trifluoromethyl, lower alkyl, aryl, aryl-lower alkyl, cycloalkyl, cycloalkyl-lower alkyl, and:
- 16
- R8 is selected from the group consisting of hydrogen, lower alkyl, aryl, cycloalkyl, aryl-lower alkyl, and cycloalkyl-lower alkyl;
- R9 is selected from the group consisting of hydroxy and acyloxy;
- R10 is selected from the group consisting of hydrogen and lower alkyl;
- with the proviso that R9 and R10 collectively optionally represent oxo;
- W is selected from the group consisting of —O— and —S—;
- X is selected from the group consisting of —NR7, S, and O;
- R5 is selected from the group consisting of hydrogen, lower alkyl, and aryl-lower alkyl and R6 is hydrogen;
- with the proviso that when X is —NR7, R5 and R6 together are optionally oxo;
- R7 is selected from the group consisting of hydrogen and lower alkyl;
- and
- Z is selected from the group consisting of carboxyl and carboxyl derivatized as a pharmaceutically acceptable ester or amide.
14 more elements
A method according to any of the preceding claims wherein the administration is topical.
Dependencies are inferred from the claim text.